fluoromisonidazole has been researched along with Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Chang, CW; Chang, TJ; Chou, TK; Lin, WJ; Liu, RS; Wang, HE; Wang, SJ; Wu, CY | 1 |
| Bentzen, L; Buus, S; Keiding, S; Mortensen, LS; Munk, OL; Nordsmark, M; Overgaard, J | 1 |
| Conrad, EU; Eary, JF; Krohn, KA; Link, JM; Mankoff, DA; Muzi, M; White, JK | 1 |
3 other study(ies) available for fluoromisonidazole and Sarcoma
| Article | Year |
|---|---|
Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
Topics: Animals; Autoradiography; Cell Line, Tumor; Diagnosis, Differential; Disease Models, Animal; Fluoroacetates; Fluorodeoxyglucose F18; Inflammation; Male; Mice; Misonidazole; Positron-Emission Tomography; Radioactive Tracers; Sarcoma; Tissue Distribution | 2009 |
Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
Topics: Biosensing Techniques; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Hypoxia; Microchemistry; Microelectrodes; Misonidazole; Neoplasms; Oxygen; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2010 |
Multiagent PET for risk characterization in sarcoma.
Topics: Carbon Dioxide; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Isotope Labeling; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Sarcoma; Thymidine; Verapamil | 2011 |